179 related articles for article (PubMed ID: 37704696)
1. Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment.
Burmeister T; Gröger D; Gökbuget N; Spriewald B; Starck M; Elmaagacli A; Hoelzer D; Keller U; Schwartz S
Sci Rep; 2023 Sep; 13(1):15167. PubMed ID: 37704696
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG
Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874
[TBL] [Abstract][Full Text] [Related]
4. Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
Ribera J; Granada I; Morgades M; González T; Ciudad J; Such E; Calasanz MJ; Mercadal S; Coll R; González-Campos J; Tormo M; García-Cadenas I; Gil C; Cervera M; Barba P; Costa D; Ayala R; Bermúdez A; Orfao A; Ribera JM;
Br J Haematol; 2022 Feb; 196(3):670-675. PubMed ID: 34549416
[TBL] [Abstract][Full Text] [Related]
5. [Clinical Significance of Minimal Residual Disease in Pediatric Patients with
Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1303-1308. PubMed ID: 37846676
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
[TBL] [Abstract][Full Text] [Related]
7. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
[TBL] [Abstract][Full Text] [Related]
8. Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes.
Huang YJ; Coustan-Smith E; Kao HW; Liu HC; Chen SH; Hsiao CC; Yang CP; Jaing TH; Yeh TC; Kuo MC; Lai CL; Chang CH; Campana D; Liang DC; Shih LY
J Formos Med Assoc; 2017 Oct; 116(10):774-781. PubMed ID: 28063722
[TBL] [Abstract][Full Text] [Related]
9. Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.
Eldfors S; Kuusanmäki H; Kontro M; Majumder MM; Parsons A; Edgren H; Pemovska T; Kallioniemi O; Wennerberg K; Gökbuget N; Burmeister T; Porkka K; Heckman CA
Leukemia; 2017 Jan; 31(1):51-57. PubMed ID: 27461063
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia.
Barber KE; Harrison CJ; Broadfield ZJ; Stewart AR; Wright SL; Martineau M; Strefford JC; Moorman AV
Genes Chromosomes Cancer; 2007 May; 46(5):478-86. PubMed ID: 17311319
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1-Positive Pediatric Acute Lymphoblastic Leukemia in China.
Wang Y; Xue YJ; Lu AD; Jia YP; Zuo YX; Zhang LP
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e137-e144. PubMed ID: 33221150
[TBL] [Abstract][Full Text] [Related]
12. Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing.
Salim M; Heldt F; Thomay K; Lentes J; Behrens YL; Kaune B; Möricke A; Cario G; Schieck M; Hofmann W; Davenport C; Steinemann D; Schrappe M; Schlegelberger B; Göhring G
Genes Chromosomes Cancer; 2022 Jan; 61(1):22-26. PubMed ID: 34460133
[TBL] [Abstract][Full Text] [Related]
13. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia.
Privitera E; Kamps MP; Hayashi Y; Inaba T; Shapiro LH; Raimondi SC; Behm F; Hendershot L; Carroll AJ; Baltimore D
Blood; 1992 Apr; 79(7):1781-8. PubMed ID: 1348433
[TBL] [Abstract][Full Text] [Related]
14. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
[TBL] [Abstract][Full Text] [Related]
15. Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.
Rowsey RA; Smoley SA; Williamson CM; Vasmatzis G; Smadbeck JB; Ning Y; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
Blood Cancer J; 2019 Oct; 9(10):81. PubMed ID: 31575852
[TBL] [Abstract][Full Text] [Related]
16. [E2A gene in t(1;19)-ALL].
Hayashi Y
Nihon Rinsho; 1992 Jun; 50(6):1369-73. PubMed ID: 1355570
[TBL] [Abstract][Full Text] [Related]
17. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.
Hunger SP; Galili N; Carroll AJ; Crist WM; Link MP; Cleary ML
Blood; 1991 Feb; 77(4):687-93. PubMed ID: 1671560
[TBL] [Abstract][Full Text] [Related]
18. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
[TBL] [Abstract][Full Text] [Related]
19. Pediatric acute lymphoblastic leukemia with t(1;19)/TCF3-PBX1 in Taiwan.
Yen HJ; Chen SH; Chang TY; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Chang TK; Peng CT; Lin MT; Jaing TH; Liu HC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Hung GY; Wu KH; Yeh TC; Wang SC; Chen RL; Chang HH; Yang YL; Chen SH; Cheng SN; Chang YH; Chen BW; Hsieh YL; Huang FL; Ho WL; Wang JL; Chang CY; Chao YH; Lin PC; Chen YC; Liao YM; Lin TH; Shih LY; Liang DC
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436581
[TBL] [Abstract][Full Text] [Related]
20. [A clinical and laboratory study of TCF3-PBX1 positive adult acute lymphoblastic leukemia.].
Zheng JF; Qiu HY; Pan JL; Cen JN; Wu YF; Zhang J; Wu DP; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):16-20. PubMed ID: 20302770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]